Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
Clinical trial NCT00336856 · COMPLETED
Trial details
- NCT number
- NCT00336856
- Sponsor
- University of Pittsburgh
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2011-06-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.